Variable | Continuation phase treatment regimen | Total | P value | ||
---|---|---|---|---|---|
6EH (n = 395) n (%) | 4RH (n = 395) n (%) | ||||
Age (years) | Mean ± SDa | 31.1 ± 12.9 | 30.5 ± 11.9 | 30.8 ± 12.4 | 0.5 |
Gender | Male | 221 (55.9) | 226 (57.2) | 447 (56.6) | 0.7 |
Female | 174 (44.1) | 169 (42.8) | 343 (43.4) | ||
Residence | Urban | 175 (44.3) | 175 (44.3) | 350 (44.3) | 1 |
Rural | 220 (55.7) | 220 (55.7) | 440 (55.7) | ||
Zone | Kaffa | 106 (26.8) | 104 (26.3) | 210 (26.6) | 0.9 |
Bench Maji | 206 (52.2) | 203 (26.3) | 409 (51.8) | ||
Sheka | 83 (21.0) | 88 (22.3) | 171 (21.6) | ||
Treatment center | Hospital | 55 (13.9) | 49 (12.4) | 104 (13.2) | 0.5 |
Health center | 340 (86.1) | 346 (87.6) | 686 (86.8) | ||
Baseline weight | Mean ± SDa | 47.6 ± 8.6 | 48.4 ± 8.5 | 48 ± 8.5 | 0.2 |
Baseline sputum smear | Positive | 186 (47.1) | 173 (43.8) | 359 (45.4) | 0.6 |
Negative | 151 (38.2) | 165 (41.8) | 316 (40) | ||
Unknown | 58 (14.7) | 57 (14.4) | 115 (14.6) | ||
Type of TB | Pulmonary | 303 (76.7 | 305 (77.2) | 608 (77.0) | 0.9 |
Positive | 186 (47.1) | 173 (43.8) | 359 (45.4) | ||
Negative | 117 (30.4) | 132 (33.4) | 252 (31.9) | ||
Extra pulmonary | 92 (23.3) | 90 (22.8) | 179 (23) | ||
HIV status | Positive | 37 (9.4) | 40 (10.1) | 77 (9.7) | <0.001 |
Negative | 246 (62.3) | 289 (73.2) | 535 (67.7) | ||
Unknown | 112 (28.4) | 66 (16.7) | 178 (22.5) | ||
Received CPTb (n = 77) | Yes | 18 (48.6) | 17 (42.5) | 35 (45.5) | 0.6 |
Received CPT or ARTc (n = 77) | Yes | 6 (16.2) | 6 (15.0) | 12 (15.6) | 0.8 |
Received ART (n = 77) | Yes | 12 (32.4) | 9 (22.5) | 21 (27.3) | 0.3 |
Baseline sputum smear | Positive | 186 (47.1) | 173 (43.8) | 359 (45.4) | 0.6 |
Negative | 151 (38.2) | 165 (41.8) | 316 (40) | ||
Unknown | 58 (14.7) | 57 (14.4) | 115 (14.6) |